BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Onay A, Ertaş A, Süzerer V, Yener İ, Yilmaz MA, Ayaz-Tilkat E, Ekinci R, Bozhan N, Irtegün-Kandemir S. Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy? Turk J Biol 2021;45:570-87. [PMID: 34803455 DOI: 10.3906/biy-2105-73] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Janecki M, Graczyk M, Lewandowska AA, Pawlak Ł. Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection. IJMS 2022;23:4170. [DOI: 10.3390/ijms23084170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Herrera-gómez Paula M, Echeverri-cataño Luis F, Giraldo S, Ruiz Colorado- Y, Vélez van Meerbeke A. Cannabis potential effects to prevent or attenuate SARS-COV2 contagion.. [DOI: 10.1101/2022.03.31.22273181] [Reference Citation Analysis]
3 Vallée A. Cannabidiol and SARS-CoV-2 Infection. Front Immunol 2022;13:870787. [DOI: 10.3389/fimmu.2022.870787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Santos S, Barata P, Charmier A, Lehmann I, Rodrigues S, Melosini MM, Pais PJ, Sousa AP, Teixeira C, Santos I, Rocha AC, Baylina P, Fernandes R. Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy. Front Immunol 2022;13:841459. [PMID: 35242142 DOI: 10.3389/fimmu.2022.841459] [Reference Citation Analysis]